Evaluating the effectiveness of Moringa oleifera leaf capsules in controlling glycemic and hypertension levels in type 2 diabetes patients
Moringa oleifera (MO) phytochemicals and therapeutic properties improve hyperglycemia and treat type 2 diabetes. Thus, this study examined the effects of MO leaf capsules on blood glucose management in type 2 diabetic mellitus (T2DM) and hypertension and their safety. A prospective placebo-controlled experiment randomly assigned 24 patients to receive 3g and 6g of MO leaf capsules twice a day or a placebo for three months. Pre- and post-study lab and clinical outcomes were assessed. The placebo control group and 3g MO leaf showed a minor change, whereas 6g and control placebo showed a considerable drop in examined features. MO usage was safe. In T2DM patients, MO leaves lowered blood pressure, requiring further study. MO leaves may help T2DM patients manage blood pressure and blood sugar, according to the study. MO's therapeutic components need more research.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Pakistan journal of pharmaceutical sciences - 36(2023), 4(Special) vom: 05. Juli, Seite 1343-1347 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hameed, Mishal [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.08.2023 Date Revised 23.08.2023 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM361045948 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361045948 | ||
| 003 | DE-627 | ||
| 005 | 20231226084321.0 | ||
| 007 | tu | ||
| 008 | 231226s2023 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1203.xml |
| 035 | |a (DE-627)NLM361045948 | ||
| 035 | |a (NLM)37606026 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hameed, Mishal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluating the effectiveness of Moringa oleifera leaf capsules in controlling glycemic and hypertension levels in type 2 diabetes patients |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 23.08.2023 | ||
| 500 | |a Date Revised 23.08.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Moringa oleifera (MO) phytochemicals and therapeutic properties improve hyperglycemia and treat type 2 diabetes. Thus, this study examined the effects of MO leaf capsules on blood glucose management in type 2 diabetic mellitus (T2DM) and hypertension and their safety. A prospective placebo-controlled experiment randomly assigned 24 patients to receive 3g and 6g of MO leaf capsules twice a day or a placebo for three months. Pre- and post-study lab and clinical outcomes were assessed. The placebo control group and 3g MO leaf showed a minor change, whereas 6g and control placebo showed a considerable drop in examined features. MO usage was safe. In T2DM patients, MO leaves lowered blood pressure, requiring further study. MO leaves may help T2DM patients manage blood pressure and blood sugar, according to the study. MO's therapeutic components need more research | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Capsules |2 NLM | |
| 700 | 1 | |a Bharadwaj, Alok |e verfasserin |4 aut | |
| 700 | 1 | |a Mumtaz, Mamoona |e verfasserin |4 aut | |
| 700 | 1 | |a Hussain, Mumtaz |e verfasserin |4 aut | |
| 700 | 1 | |a Goyal, Mayank |e verfasserin |4 aut | |
| 700 | 1 | |a Fatima, Nida |e verfasserin |4 aut | |
| 700 | 1 | |a Juyal, Ashima |e verfasserin |4 aut | |
| 700 | 1 | |a Hani, Thamer |e verfasserin |4 aut | |
| 700 | 1 | |a Mahjoob Khalaf, Othman |e verfasserin |4 aut | |
| 700 | 1 | |a M Aljowaie, Reem |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Tse-Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Abdul Salam, Maria |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pakistan journal of pharmaceutical sciences |d 1988 |g 36(2023), 4(Special) vom: 05. Juli, Seite 1343-1347 |w (DE-627)NLM09369900X |x 1011-601X |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2023 |g number:4(Special) |g day:05 |g month:07 |g pages:1343-1347 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2023 |e 4(Special) |b 05 |c 07 |h 1343-1347 | ||